Document
type: Class

Academic Article
type: Class

Inglese
type: Language

Continuant
type: Class

Entity
type: Class

Generically Dependent Continuant
type: Class

13057557
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Phase II study of afatinib, an irreversible ErbB family blocker, in EGFR FISH-positive non-small-cell lung cancer

Article
type: Class

Information Content Entity
type: Class

Phase II study of afatinib, an irreversible ErbB family blocker, in EGFR FISH-positive non-small-cell lung cancer
type: Thing
most specific type: Academic Article
related by: 13057557
type: Document
type: Academic Article
type: Continuant
language: Inglese
type: Information Content Entity
type: Entity
type: Generically Dependent Continuant
type: Article

RDF description of Phase II study of afatinib, an irreversible ErbB family blocker, in EGFR FISH-positive non-small-cell lung cancer - http://irises.uninsubria.it/resource/item/143816
rights: termsOfUse
date: 2026-08-26T06:36:58
publisher: Phase II study of afatinib, an irreversible ErbB family blocker, in EGFR FISH-positive non-small-cell lung cancer
type: Document